Duncan Bucknell

Strategic Intellectual Property

Menu

Our Services
Insights & News
How we help you succeed
About us

Duncan Bucknell

Strategic Intellectual Property

Broad claim scope invalidates UK Nicorandil formulation patent despite ‘powerful arguments’ to the contrary

Posted on April 11, 2006 By Duncan

Share this:

Email
LinkedIn
X
Facebook
Reddit
Pinterest
Tumblr
Threads
WhatsApp

Like this:

Like Loading…

Related

← Spring-boarding to catch up with the rest of the world:

US CAFC upholds Aventis Lovenox (enoxaparin) patent enforceability →

Category: Pursue Excellence

Duncan Bucknell

duncan@duncanbucknell.com

+61 427 003 423

Search

Type your email…

Insights & News

Commercial IP, deals and contracts
Disputes and Litigation
IP Rights
Strategic Advice

Duncan Bucknell

Discover more from Duncan Bucknell

Subscribe now to keep reading and get access to the full archive.

Type your email…

Continue reading

Go to mobile version

%d